Alpramil 12 mg/30 mg Film-coated Tablets for Cats Weighing at Least 3 kg

In order to develop an effective worm control programme local epidemiological
information and the risk of exposure of the cat should be taken into account.
It is recommended to treat all the animals living in the same household
concomitantly.
When infection with the cestode D. caninum has been confirmed, concomitant
treatment against intermediate hosts, such as fleas and lice, should be discussed
with a veterinarian to prevent re-infection.
Parasite resistance to any particular class of anthelmintic may develop following
frequent, repeated use of an anthelmintic of that class. Unnecessary use of
antiparasitics or use deviating from the instructions may increase the resistance
selection pressure and lead to reduced efficacy.

Special precautions for safe use in the target species:
No studies have been performed with severely debilitated cats or individuals with
seriously compromised kidney or liver function. The veterinary medicinal product is
not recommended for such animals or only according to a benefit/risk assessment by
the responsible veterinarian.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
This veterinary medicinal product may be harmful when ingested, particularly for
children.
Avoid accidental ingestion.
AN: 02391/2025 & 02646/2025
The veterinary medicinal product should be stored in a safe place.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
Other precautions:
Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable
disease to the World Organisation for Animal Health (WOAH), specific guidelines on
the treatment and follow-up and on the safeguard of persons need to be obtained
from the relevant competent authority.